top of page

Massachusetts Lawmakers Approve Bills To Protect Marijuana Users From Employment Discrimination And Expand Medical Cannabis Program

  • Writer: Bob Marley
    Bob Marley
  • Sep 3, 2025
  • 3 min read

Massachusetts lawmakers have advanced a pair of bills that would provide employment protections for marijuana consumers and expand the state’s medical cannabis program, in part by adding post-traumatic stress disorder (PTSD) and opioid use disorder to the list of qualifying conditions.

The legislature’s Joint Committee on Cannabis Policy reported the two measures out favorably on Tuesday.

Rep. Michael Soter (R) sponsored the medical marijuana expansion legislation, which would amend the existing state statute to include PTSD and opioid use disorder as conditions that could qualify patients for cannabis if recommended by a doctor.

Additionally, the bill would revise the statute to make it so military veterans who receive health care from the U.S. Department of Veterans Affairs (VA) could qualify for medical cannabis if they provide documentation “indicating a diagnosis of a debilitating medical condition.”

The other bill that moved through the joint committee, sponsored by Rep. Michael Kushmerek (D), would bar employers from refusing to hire, terminate or under-compensate a worker based on the presence of THC metabolites in a drug test, “unless reasonable suspicion exists that the employee was impaired by marijuana at the employee’s place of employment or during the hours of employment.”

Further, the legislation would make it so it “shall be a defense to such employment action if the employee, due to the presence of tetrahydrocannabinol or marijuana metabolite in the blood, urine or other body sample provided by the individual, is unable to maintain licenses, credentials, or other qualifications that are reasonably necessary for the performance of the employee’s position, regardless of whether such licensing, credentialing, or other qualifications prohibit the employee from using marijuana.”

“This section shall not apply to safety sensitive positions or if compliance would cause the employer to commit a violation of a federal law, regulation, contract, or funding agreement,” the bill text states.

As the measures are advancing, the attorney general of Massachusetts recently published dozens of proposed initiatives for the 2026 ballot—including a pair that would roll back adult-use marijuana legalization in the state.

The two marijuana measures—which would eliminate the commercial adult-use market while maintaining patient access under the medical cannabis program and continuing to allow lawful possession of up to an ounce of recreational marijuana—are being spearheaded by Caroline Cunningham, who previously fought against a psychedelics legalization ballot initiative that voters ultimately rejected last year.

Whether the cannabis measures will make the ballot is yet to be seen. Voters approved legalization at the ballot in 2016, with sales launching two years later. And the past decade has seen the market evolve and expand. As of last month, Massachusetts officials reported more than $8 billion in adult-use marijuana sales.

—Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.—

Regulators are also working to finalize rules to allow for a new cannabis consumption lounge license type, which they hope to complete by October.

Separately, in May, the Cannabis Control Commission (CCC) launched an online platform aimed at helping people find jobs, workplace training and networking opportunities in the state’s legal cannabis industry.

State lawmakers have also been considering setting tighter restrictions on intoxicating hemp-derived products and a plan to allow individual entities to control a larger number of cannabis establishments.

Also in Massachusetts, legislators who were working on a state budget butted heads with CCC officials, who’ve said they can’t make critical technology improvements without more money from the legislature.

Photo courtesy of Mike Latimer.

Recent Posts

See All

Comments


Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page